questionText: To ask the Secretary of State for Foreign, Commonwealth and Development Affairs, whether he has made an assessment of the potential merits of taking steps with his with African counterparts to support the use of (a) Lenacapavir and (b) other long-lasting HIV prevention drugs among high-risk populations.
answerText: Long-acting technologies could be game-changers in the global response to HIV, but only if they reach the countries and communities that need them most, including young women and girls in sub-Saharan Africa and the most vulnerable and marginalised groups ...
heading: Africa: HIV Infection